Clinical trial
Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone…
NCT00039546 · Cancer Research Campaign Clinical Trials Centre, Other · Unknown status
Key facts
| NCT number | NCT00039546 |
|---|---|
| Title | Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery |
| Official title | 'tAnGo', A Phase III Randomised Trial Of Gemcitabine In Paclitaxel-Containing, Epirubicin-Based, Adjuvant Chemotherapy For ER/PgR-Poor, Early Stage, Breast Cancer |
| Lead sponsor | Cancer Research Campaign Clinical Trials Centre, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cyclophosphamide, epirubicin hydrochloride, gemcitabine hydrochloride, paclitaxel, adjuvant therapy |
| Start date | Aug 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 7, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: